FDA Limits COVID-19 Vaccine Access to High-Risk Groups Amid Controversial New Framework
The FDA's new policy restricts COVID-19 vaccinations to high-risk groups, a significant change that raises concerns over access and insurance coverage.
New Trump vaccination policy limits access to COVID-19 shots
Chicago Sun-Times
FDA to require trials for COVID boosters for healthy adults and children
Washington Examiner
Overview
In a significant policy shift, the FDA will no longer approve annual COVID-19 vaccinations for healthy younger adults and children, focusing on those aged 65 and older and individuals with underlying health conditions. This new approach, detailed in an article by top officials in the New England Journal of Medicine, bypasses traditional advisory committees. Critics view this as a move influenced by anti-vaccine advocacy and are concerned it could limit vaccine accessibility and insurance coverage for millions of Americans, who may now need to provide evidence of high-risk status to qualify for vaccinations.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
- The FDA has shifted to requiring extensive clinical trials for COVID-19 vaccines for healthy adults, which could reduce access for many who wanted vaccinations.
- While vaccines will still be available for high-risk groups, the new guidelines raise concerns about the accessibility of vaccines for the general population, especially healthy individuals.
- Experts express confusion and concern over the FDA's decision to bypass usual consultative processes typically handled by the CDC regarding vaccine recommendations.
Articles (19)
No highlight available for this article.
PBS NewsHour·1M·No highlight available for this article.
Boston Globe·1M·No highlight available for this article.
TIME Magazine·1M·No highlight available for this article.
CNN·1M·No highlight available for this article.
NBC News·1M·No highlight available for this article.
Chicago Sun-Times·1M·No highlight available for this article.
NPR·1M·No highlight available for this article.
USA TODAY·1M·No highlight available for this article.
ABC News·1M·No highlight available for this article.
CBS News·1M·No highlight available for this article.
ARS Technica·1M·No highlight available for this article.
Associated Press·1M·No highlight available for this article.
Boston Herald·1M·No highlight available for this article.
FOX News·1M·No highlight available for this article.
Washington Examiner·1M·No highlight available for this article.
Newsmax·1M·No highlight available for this article.
Daily Caller·1M·No highlight available for this article.
Daily Signal·1M·No highlight available for this article.
Infowars·1M·FAQ
The FDA's new policy allows COVID-19 vaccines for adults 65 and older and those with underlying health conditions that increase the risk of severe COVID-19 outcomes.
For healthy children and adults, the FDA will require randomized, placebo-controlled data assessing clinical outcomes before approving COVID-19 vaccines.
The FDA shifted its policy due to poor uptake of yearly COVID boosters and declining public trust in vaccines, aiming for a more targeted approach.
About 100 million to 200 million Americans may still qualify for updated COVID-19 vaccines, as they fall into the high-risk category or are 65 and older.
Examples of underlying conditions include obesity, pregnancy, diabetes, and certain mental health conditions like depression.
History
- 1M14 articles
- 1M4 articles
- 1M6 articles